Illumina to appeal after European Commission prohibits $7.1 billion GRAIL acquisition
September 06, 2022 at 17:10 PM EDT
Illumina announced Tuesday it plans to appeal the European Commission's decision to prohibit the company's acquisition of cancer detection company GRAIL.
